- Home
- NNAVW vs GNLX Comparison
NNAVW vs GNLX Comparison
Compare NNAVW & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$7.58
HOLD
Current Price
$4.35
Company Overview
Basic Information| Metric | NNAVW | GNLX |
|---|---|---|
| Founded | 2007 | 2001 |
| Country | United States | United States |
| Employees | 96 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 202.4M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | NNAVW | GNLX |
|---|---|---|
| Price | $7.58 | $4.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $19.75 |
| AVG Volume (30 Days) | 53.1K | ★ 146.6K |
| Earning Date | 03-12-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,963,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 43.44 | N/A |
| 52 Week Low | $4.47 | $1.99 |
| 52 Week High | $4.70 | $8.54 |
Technical Indicators
Market Signals| Indicator | NNAVW | GNLX |
|---|---|---|
| Relative Strength Index (RSI) | 66.52 | 42.02 |
| Support Level | $7.26 | $4.10 |
| Resistance Level | $7.65 | $4.37 |
| Average True Range (ATR) | 0.41 | 0.29 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 71.52 | 39.21 |
Price Performance
Historical Comparison NNAVW
GNLX
About NNAVW NextNav Inc. Warrant
NextNav Inc provides GPS service. The company NextNav TerraPoiNT system keeps critical infrastructure resilient with reliable Position, Navigation, and Timing services in the absence of GPS.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.